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Background
While it has long been know that phosphorylation of the
kinase homology domain is a key regulatory mechanism
of natriuretic peptide receptors, no biochemical proof for
individual phosphorylation sites has been reported. Here,
we describe biochemical verification of previously identi-
fied phosphorylation sites in both natriuretic peptide
receptor A (NPR-A) and natriuretic peptide receptor B
(NPR-B) as well as the identification of novel phosphor-
ylation sites in both receptors.
Methods and results
Natriuretic peptide receptors were immunoprecipitated
and separated by gel electrophoresis. Isolated receptors
were digested in the gel by tryptic digestion and individual
phosphopeptides were detected with a LTQ-Orbitrap XL
hybrid Fourier transform mass spectrometer. Tandem
mass spectrometry of the tryptic peptide mixture revealed
phosphorylation at all of the previously identified phos-
phorylation sites within NPR-A and NPR-B. Evidence of
additional uncharacterized phosphorylation sites was
also obtained. Functional consequences of these individ-
ual phosphorylation sites were determined through the
use of alanine and glutamate point mutations, which
mimic the dephosphorylated and phosphorylated recep-
tor, respectively.
Conclusion
Using mass spectrometric techniques, we have success-
fully verified known natriuretic peptide receptor phos-
phorylation sites as well as identified additional novel
phosphorylation sites. Possible functional consequences
of these putative sites on receptor activation as deter-
mined by alanine and glutamate substitutions will be dis-
cussed.
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